Medicare Carriers Denying Self-Injectable Drug Coverage Despite Mandate
Executive Summary
Medicare's South Carolina carrier is refusing coverage for enoxaparin (Aventis' Lovenox), dalteparin (Pharmacia Fragmin) and interferon (Schering-Plough's Intron A) because they can be self-administered, despite a 1999 Congressional mandate requiring coverage, a South Carolina oncologist reported to a May 18 HCFA Town Hall meeting.